Korean J Thorac Cardiovasc Surg.  2013 Dec;46(6):449-456.

Prognosis of Recurrence after Complete Resection in Early-Stage Non-Small Cell Lung Cancer

Affiliations
  • 1Department of Thoracic and Cardiovascular Surgery, Dong-A University College of Medicine, Korea. ssjeong49@hanmail.net

Abstract

BACKGROUND
Tumor recurrence is the most common cause of treatment failure, even after complete resection of early-stage non-small cell lung cancer (NSCLC). In this study, we investigated the prognosis of patients with early recurrence in order to identify independent risk factors related to early recurrence.
METHODS
Between February 1995 and December 2012, 242 patients who underwent surgical resection for stage I NSCLC at Dong-A University Hospital were reviewed. The factors predicting overall survival (OS) and early recurrence were investigated. We also investigated the relationship between the patterns and period of recurrence and clinicopathological factors.
RESULTS
For patients with stage IA and IB NSCLC, the 5-year OS rate was 75.7% and 57.3% (p=0.006), respectively. A multivariate Cox proportional hazards model demonstrated that gender (p=0.004), comorbidity number (p=0.038), resection type (p=0.002), and tumor size (p=0.022) were the statistically significant predictors of OS. Moreover, the multivariate analysis revealed that smoking history (p=0.023) and histologic grade (p=0.012) were the independent predictors of early recurrence. Additionally, only histologic grade (poor differentiation) was found to be significantly associated with a higher frequency of distant metastasis; there was no relationship between the patterns and period of recurrence and clinicopathological factors.
CONCLUSION
The present study demonstrated that smoking history and histologic grade were independent prognostic factors for early recurrence within two years in patients with early-stage NSCLC. Patients with these predictive factors may be good candidates for adjuvant therapy.

Keyword

Carcinoma, non-small cell, lung; Recurrence; Surgery; Risk factors; Adjuvant therapy

MeSH Terms

Carcinoma, Non-Small-Cell Lung*
Comorbidity
Humans
Multivariate Analysis
Neoplasm Metastasis
Prognosis*
Proportional Hazards Models
Recurrence*
Risk Factors
Smoke
Smoking
Treatment Failure
Smoke
Full Text Links
  • KJTCS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr